ReviewMolecular cancer therapeutics2026

Proteolysis Targeting Chimeric-Based Technology in Myeloma and Lymphoma.

Adrian Bogdan Tigu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.